BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 14716741)

  • 1. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
    Bostwick DG; Qian J; Maihle NJ
    Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
    Tamboli P; Amin MB; Xu HJ; Linden MD
    Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer.
    Bostwick DG; Alexander EE; Singh R; Shan A; Qian J; Santella RM; Oberley LW; Yan T; Zhong W; Jiang X; Oberley TD
    Cancer; 2000 Jul; 89(1):123-34. PubMed ID: 10897009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
    Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
    Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases.
    Hull D; Ma J; Singh H; Hossain D; Qian J; Bostwick DG
    BJU Int; 2009 Oct; 104(7):915-8. PubMed ID: 19388995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia.
    Montironi R; Lucarini G; Castaldini C; Galluzzi CM; Biagini G; Fabris G
    Anticancer Res; 1996; 16(4A):2057-62. PubMed ID: 8712742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.
    Quick CM; Gokden N; Sangoi AR; Brooks JD; McKenney JK
    Hum Pathol; 2010 Aug; 41(8):1145-9. PubMed ID: 20413145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Jiang J; Ulbright TM; Zhang S; Eckert GJ; Kao C; Gardner TA; Koch MO; Eble JN; Cheng L
    Cancer; 2002 Jul; 95(2):296-300. PubMed ID: 12124829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia.
    Patton KT; Chen HM; Joseph L; Yang XJ
    Histopathology; 2005 Dec; 47(6):597-601. PubMed ID: 16324197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
    Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
    Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
    Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
    Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
    Pacelli A; Bostwick DG
    Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic markers in prostatic intraepithelial neoplasia: immunohistochemical and cytogenetic analyses.
    Tsuji M; Kanda K; Murakami Y; Kurokawa Y; Kanayama H; Sano T; Kagawa S
    J Med Invest; 1999 Feb; 46(1-2):35-41. PubMed ID: 10408155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Mohamed MA; Greif PA; Diamond J; Sharaf O; Maxwell P; Montironi R; Young RA; Hamilton PW
    BJU Int; 2007 Apr; 99(4):908-15. PubMed ID: 17378849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of ezrin in prostatic intraepithelial neoplasia.
    Pang ST; Fang X; Valdman A; Norstedt G; Pousette A; Egevad L; Ekman P
    Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia.
    Maygarden SJ; Strom S; Ware JL
    Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
    Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
    J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma.
    Bostwick DG; Meiers I; Shanks JH
    Hum Pathol; 2007 Sep; 38(9):1394-401. PubMed ID: 17555796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.